Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming

Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming

Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming, Published online: 18 January 2019; doi:10.1038/s41467-018-08245-z

There are distinct hypermethylation patterns in gene promoters in hepatocellular carcinomas (HCCs). Here, the authors show that the enhancer of C/EBPβ is recurrently hypomethylated in human HCCs, recapitulating this in a transgenic murine model and linking aberrant enhancer hypomethylation to hepatocarcinogenesis.

from A via a.sfakia on Inoreader https://go.nature.com/2TVEyN1